ACM
WVE icon

Altium Capital Management’s Wave Life Sciences WVE Stock Holding History

Altium Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-398,997
Closed -$2.24M – 157
2021
Q1 		$2.24M Buy
+398,997
New +$3.83M 0.62% 67

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Altium Capital Management's WVE Position: Q2 2021 in Review

Altium Capital Management sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 398,997 shares — an estimated $2.24M sold.

Altium Capital Management first reported a position in WVE in Q1 2021 and held it in 1 quarter. The position peaked at $2.24M in Q1 2021. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

  • Altium Capital Management reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Altium Capital Management sold 398,997 Wave Life Sciences shares in Q2 2021, an estimated $2.24M.
  • Altium Capital Management first reported a position in Wave Life Sciences in Q1 2021 and held it in 1 quarter.
  • Altium Capital Management's Wave Life Sciences position peaked at $2.24M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Altium Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.